Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1954;10(5):781–788.

Antiserum in the prophylaxis of rabies*

Karl Habel
PMCID: PMC2542175  PMID: 13182600

Abstract

This paper reviews recent experimental evidence in support of inoculation with antirabies serum, the value of which, as a prophylactic measure, is compared with that of vaccine treatment alone. The author concludes that the chief advantages of combined antiserum-vaccine prophylaxis lie in the rapid treatment of cases who have suffered severe exposure, and in the possibility of reducing the incidence of post-vaccinal complications.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. KOPROWSKI H., COX H. R. Recent developments in the prophylaxis of rabies. Am J Public Health Nations Health. 1951 Dec;41(12):1483–1489. doi: 10.2105/ajph.41.12.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. KOPROWSKI H., VAN DER SCHEER J., BLACK J. Use of hyperimmune anti-rabies serum concentrates in experimental rabies. Am J Med. 1950 Apr;8(4):412–420. doi: 10.1016/0002-9343(50)90224-5. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES